Internal Medicine - 1
Internal Medicine - 1
Case 1 AG
Duration -5 minutes
You are a local therapist at the Central District Hospital. You are approached by a 55-year-old man, an accountant,
with complaintsfor headaches, nausea, flies before the eyes.
Previously, he did not go to the doctors, did not measure blood pressure. Deterioration of the general condition notes
within 3 days. He took aspirin, citramon - without effect. On the second day of illness, the doctor of the ambulance
team recordedrise in blood pressure to 165/100 mm Hg, and after taking 1 tablet of captopril 25 mg, blood pressure
decreased to 140/90 mm Hg. On the third day, due to an increase in blood pressure to 175/110 mm Hg, he went to
the emergency room of the Central District Hospital.
From the anamnesis: Works as an accountant, work is associated with constant stress. Smokes a lot.
Indulges in salty foods. She has been suffering from diabetes for a year. Takes 1 diabeton tablet in the morning. The
mother suffered from arterial hypertension for many years.
Objectively: height 178 cm, weight 99 kg. BMI 32. OT-102cm. Restless, can answer questions. The face is
hyperemic. There are no peripheral edema. Vesicular breathing in the lungs, no wheezing. NPV 20 times per minute.
The left border of relative cardiac dullness was expanded by 2-2.5 cm. Heart sounds are muffled, the rhythm is
correct. Pulse 96 per minute. BP 175/105 mmHg The liver is not enlarged.
Research:
General blood analysis:Hb - 145 g / l, erythrocytes - 4.8x1012 / l, leukocytes - 5.6x109, stab neutrophils - 2%,
segmented neutrophils - 67%, eosinophils - 2%, basophils - 1%, monocytes - 5%, lymphocytes - 25%, ESR - 10
mm/h.
Blood chemistry:creatinine - 59 µmol/l, glucose - 5.3 mmol/l, total cholesterol - 6.6 mmol/l, HDL 0.8 mmol/l, LDL 3.53
mmol/l, TG 2.0 mmol/l, ALT - 16 IU. ECG:
Clinical Details: You- Clinical doctor. A 57-year-old man came to your appointment with intense pain behind the
sternum.
Complaints: burning pain behind the sternum, a feeling of lack of air, increased sweating, weakness. Pain appeared
after exercise, lasting about one hour. I took nitroglycerin tablets under the tongue twice, the condition was somewhat
relieved, but the pain did not go away. The last time I took nitroglycerin was 5 minutes ago.
History:Consists on "D" accounting with coronary artery disease and currents of 5 years. Periodically takes
bisoprolol 5 mg, cardiomagnyl 75 mg. Consists on the D account with AG. The maximum increase in blood pressure
is up to 160\100mm. Hg Regularly takes antihypertensive drugs. He smokes 1 pack of cigarettes a day.
Mom suffered from coronary artery disease and died at the age of 65 from a heart attack. This deterioration was
about 1 hour when the above complaints appeared.
Objectively:The skin is pale, covered with cold sticky sweat. There are no peripheral edema. Vesicular
breathing in the lungs, no wheezing. NPV 20 per minute. The heart sounds are muffled, the rhythm is correct. BP
140/90 mmHg Art. Heart rate 92 beats per minute.
On the ECG
Final result:
Situational task:You are a therapist. A 55-year-old man came to the appointment with a diagnosis of CRHD. Taken an
ECG.
Interpret the ECG and write a conclusion.
Final result:
The task:
3. EFGDS:The esophagus is freely passable, the mucous membrane in the lower third for 7 mm is sharply hyperemic,
edematous, loosened. In the distal esophagus, there are single small-pointed erosions covered with fibrin. The cardiac
sphincter is hyperemic, edematous, gaping. The gastric folds open freely during insufflation. The mucous membrane
of the antrum of the stomach is pale orange in color, edematous.
Interpretation:
"GASTROESOPHAGEAL REFLUX DISEASE, B (Classification of reflux - esophagitis (Los Angeles, 1994because
there are mucosal defects (one or more) limited to one SOP fold, larger than 5 mm;)) (1 degree according to Savary
Miller classification)Reflux esophagitis, exacerbation
Urease testH. pylori - negative
3) Principles of treatment.
Non-drug treatment:
Mode: I, II, III.
Table number 2-3 (restriction of animal fats, chocolate, mint, spices, onions, coffee, tomatoes, citrus fruits, alcohol
- they all relax the lower esophageal sphincter)
● Controlled weight loss in overweight and obese individuals is an important part of the long-term management of
GERD and should not be ignored as a therapeutic measure.
● Lifestyle - light meals, avoiding late meals, avoiding triggers, using a sleep pillow (raised head end of the bed),
after eating, avoid bending forward and do not lie down, do not wear tight clothing
● Over-the-counter drugs (antacids or alginate-antacids) provide the most immediate, but usually transient, relief
of symptoms and can be taken as needed.
Medical treatment
Medicines with gastroprotective action:
Proton pump inhibitors:
● omeprazole 20-40 mg, by mouth, before meals once a day for 7 to 30 days (4-8 weeks)
● rabeprazole (in the absence of omeprazole), 20–40 mg, by mouth, once a day (7–30 days)
Prokinetics:Itopride hydrochloride 50 mg 1 cap x 3 times a day 20 minutes before meals (up to 4 weeks).
H2-histamine receptor blockers:
● ranitidine, 150 mg, 300 mg, 25 mg/ml; in / in, in / m, 1 time per day for 10 days
● famotidine (in the absence of ranitidine), 10 mg, 20 mg, 40 mg, im, once a day in
within 10 days
Antiemetics:
● ondansetron 4mg/2ml, 8mg/4ml, IM, 1x, with vomiting
● promethazine (in the absence of ondasterone), 50 mg / 2 ml; 25 mg, i.m., 1-fold, with
vomiting
Case 6
Stomach ulcer
Patient A., 44 years old, a leading engineer of the mine, complains of periodic pain in the epigastric proper, more on
the right, which occurs 20-30 minutes after eating, and significantly decreases or disappears after 1.5-2 hours. He
notes heartburn, sometimes bitterness in the mouth, appetite is preserved, stools are normal 1 time per day.
Anamnesis of the disease: for several years he noted discomfort in the epigastric proper after sour, smoked, salty
foods. He took enzymes, these phenomena disappeared. In recent months, he experienced overload at work (night
shifts), stress (pre-accident situations at the mine). He began to notice pains at first dull moderate, which were
removed by Almagel, milk. In the future, the pain intensified, especially after eating, regardless of its quality. There
was heartburn, which was often accompanied by bitterness in the mouth. He reduced the amount of food he took, but
the pain progressed, he was hospitalized in the department. He smoked ½ pack a day, has not smoked for the last 5
years.
Objectively:skin of normal color, turgor preserved. Peripheral lymph nodes are not palpable. The borders of the heart
are normal. Heart rate - 70 beats per minute, blood pressure - 130/70 mm Hg. Art. The tongue is coated with white.
The abdomen is involved in breathing. On palpation notes a slight soreness in the epigastrium. On palpation of the
intestines, pain, volumetric formations were not detected. The liver is along the edge of the costal arch, cystic
symptoms (Kera, Murphy, Ortner) are negative. The spleen is not palpable.
Data from laboratory and instrumental studies:Complete blood count: hemoglobin - 148 g/l, ESR - 4 mm/h,
erythrocytes - 5.2×1012/l, leukocytes - 7.6×109/l, eosinophils - 2%, stab neutrophils - 5%, segmented neutrophils -
56%, lymphocytes - 37%. Biochemical blood test: total protein - 82 g / l, total bilirubin - 16.4 (direct - 3.1; free - 13.3)
mmol / l, cholesterol - 3.9 mmol / l, potassium - 4.4 mmol / l, sodium - 142 mmol / l, glucose - 4.5 mmol / l.
FGDS:we pass the esophagus, the rosette of the cardia closes tightly. The mucosa in the esophagus is unchanged. In
the middle third of the stomach along the lesser curvature there is an ulcerative wall defect(mucous and submucosal)
up to 1.2 cm, the bottom of the defect is filled with fibrin, the edges of the defect are raised, edematous. On the rest of
the stomach there is a focus of dim hyperemia. DPC unchanged. 4 pieces of material were taken for biopsy. When
taking a biopsy from the edges of the ulcer, moderate neutrophilic infiltration and edema are noted.
The task:
1) Interpret the data of the laboratory and instrumental examination Make and justify a plan for additional examination
of the patient.
General blood analysis:
hemoglobin - 148 g / l - within the normal range (130-160 g / l)
ESR - 4 mm/hour - norm (1-10 mm/hour)
erythrocytes - 5.2 × 1012 / l - norm
leukocytes - 7.6 × 109 / l - normal
eosinophils - 2% - normal
stab neutrophils - 5% - normal
segmented neutrophils - 56% - normal
lymphocytes - 37% - normal
Conclusion: in the UAC, all indicators are within the normal range.
Blood chemistry:
total protein - 82 g / l - norm (64-83)
total bilirubin - 16.4 (direct - 3.1; free - 13.3) mmol / l - norm (total is normal 3.4 - 17.1)
cholesterol - 3.9 mmol / l - norm
potassium - 4.4 mmol / l - norm (3.5-5.5)
sodium - 142 mmol / l - norm (135-145)
glucose - 4.5 mmol / l - norm
Conclusion: In the biochemical blood test, all indicators are within the normal range.
The patient is advised to additionally undergo:
- research on H. p. (helicobacter pylori): sampling for cytological examination with FEGDS;
-determination of antigen H.r. ELISA method (determination of N.R. is essential, since up to 80% of gastric ulcers and
90% of duodenal ulcers are N.R. - associated).
- Ultrasound of the abdominal organs to exclude other pathologies of the abdominal organs.
-Feces for occult blood to exclude microbleeding from the ulcer. (Hemocult test, Gregersen reaction- a fecal
examination aimed at detecting asymptomatic bleeding of the digestive system.)
3) Principles of treatment
Situational task:You are a local doctor in a polyclinic. A 42-year-old woman came to you with complaints of weakness,
bitterness in the mouth, and occasional pain in the right hypochondrium. History of chronic cholecystitis for more than
5 years. An examination has been carried out.
The task:interpret laboratory tests and make a diagnosis.
General blood analysis
Hemoglobin 132 g/l - normal
Erythrocytes 4.59×1012/l — normal
CPC 0.84 - lower limit of normal
Platelets 150×109/l - thrombocytopenia
Leukocytes 3.0×109/l - leukocytopenia
Neutrophils 49% - normal
Monocytes 3% - normal
Lymphocytes 36% - normal
ESR 8 mm/h - normal
OAM:
Amount of urine - 100 ml
Color - light yellow
Transparency - transparent
Relative density - 1020 is normal (1010-1030)
pH - 6.0 normal (5-7) slightly acidic
LEU-neg
NIT - neg
PRO-neg
GLU-norm
KET-neg
UBG–neg
BIL–norm
ERI - neg
indicators are normal
Blood chemistry
Components Result Units
Iron 17.69 (N20-30) µmol/l norm
ALT 140.60 (N 19-79) U/l increased
AST 88.20 (N to 31) U/L increased
Bilirubin (total) 25.0 (N 3-17) U/L increased
GGTP(gammaglutamylt 58.00 (N 6-42) U/L increased
ranspeptidase)
AP 138.00 (N to 240) U/L norm
Syndrome of cytolysis and cholestasis
ELISA for SH markers
OPK OPP
HBsAg positive 0.240 3.124
aHBs negative
aHBcor IgG positive
HBe Ag positive
aHBe negative
aHCV total negative
aHDV IgG negative
HbsAg-primary screening marker for hepatitis B virus
aHBcor IgG- found in people who have had contact with the virus, indicate either a past illness or a chronic infection.
HBeAg-viral replication marker, present in almost all DNA-positive patients
everything else is negative
The principle of the method is to measure the stiffness of the liver parenchyma (LPP)by the propagation velocity in it
of an elastic shear wave generated by a mechanical wave. During the UTE of the liver, digital stiffness values in
kilopascals (kPa) are obtained, by which the degree of fibrosis can be determined:
2.0-5.8 kPa corresponds to the F0 stage of fibrosis (normal), 5.9-7.2 kPa - F1st,7.3-9.2kPa - F2st, 9.3-12.9kPa - F3st,
more than 13.0kPa - F4st (cirrhosis).
Diagnosis:
Chronic viral hepatitis B, HbeAg-positive, moderate viremia, moderate ALT activity, fibrosis stage F2
Additional diagnostic testscarried out at the stationary level: Biochemical profile: urea, potassium, sodium, gamma
globulins, total cholesterol, triglycerides, glucose, serum iron, ferritin, ammonia;
HBsAg (quantitative test);
anti-HAV; ceruloplasmin;
IgG; ANA: A.M.A.;
Functional tests of the thyroid gland: TSH, T4 free, Ab to TPO;
Pregnancy test; Ultrasound of the vessels of the liver and spleen; EGDS;
CT scan of the abdominal organs (with suspicion of volumetric formations and thrombosis - with intravenous
contrasting);
MRI of the abdominal organs (if volumetric formations and thrombosis are suspected - with intravenous contrast;)
MRCP; eye examination.
Non-drug treatment:
General measures:
Protective mode: avoid insolation, overheating of the body, in the advanced stages of the disease and portal
hypertension - limiting physical activity, facilitating the mode of work;
Barrier contraception during sexual intercourse with unvaccinated partners
Hepatitis vaccination
Vaccination of sexual partners against hepatitis B
Individual use of personal hygiene products
Minimization of risk factors for progression: exclusion of alcohol, tobacco, marijuana, hepatotoxic drugs, including
dietary supplements, normalization body weight, etc.
Medical treatment:
The basis of the treatment of chronic hepatitis B is antiviral therapy.
Fixed course of therapy with Peg-IFN (pegylated interferon) and, in some cases, AN
Long-term treatment with nucleotide/nucleoside analogues
Case 8 XP Pancreatitis
Patient K., 45 years old, turned to a general practitioner with complaints of pressing pains in the epigastric region,
periodically girdle pains, occur 40 minutes after eating fatty and fried foods, accompanied by bloating; on vomiting that
does not bring relief, on eructation of air.
Disease history:considers himself ill for about two years, when there was pain in the left hypochondrium after eating
fatty and fried foods. He did not seek medical help. 3 days ago, after an error in the diet, the pains resumed, bloating
appeared, belching with air, nausea, and vomiting that did not bring relief.
Objectively:condition is relatively satisfactory, consciousness is clear. Skin of normal color. In the lungs, vesicular
breathing, no wheezing. NPV - 18 per minute. Heart sounds are clear, rhythmic. Heart rate - 72 beats per minute.
Tongue wet, lined with white-yellow coating. The abdomen is soft on palpation, painful in the epigastrium and left
hypochondrium. The liver is not palpable, the dimensions according to Kurlov are 9×8×7 cm, the symptom of
effleurage is negative bilaterally.
General blood analysis: erythrocytes - 4.3 × 1012 / l, hemoglobin - 136 g / l, color index - 1.0; ESR - 18 mm/h,
platelets - 320×109 /l, leukocytes - 10.3×109 /l, eosinophils - 3%, stab neutrophils - 4%, segmented neutrophils - 51%,
lymphocytes - 32%, monocytes - 10 %.
General analysis of urine: light yellow, transparent, acidic, specific gravity - 1016, leukocytes - 1-2 in the field of view,
epithelium - 1-2 in the field of view, oxalates - a small amount.
Biochemical blood test:AST - 30 U / l; ALT - 38 U / l; cholesterol - 3.5 mmol / l; total bilirubin - 19.0 µmol/l; direct - 3.9
µmol/l; amylase - 250 units/l; creatinine - 85 mmol / l; total protein - 75 g / l.
Coprogram:color - grayish-white, consistency - dense, smell - specific, muscle fibers +++, neutral fat +++, fatty acids
and soaps +++, starch ++, connective tissue - no, mucus - no. Urease test for the presence of H. pylori is positive.
FGDS:esophagus and cardia of the stomach without features. The stomach is of normal shape and size. Mucous pink,
hyperemic. The folds are well defined. Bulb of the duodenum without features.
Ultrasound of the abdominal organs: the liver is of normal size, the structure is homogeneous, normal echogenicity,
the ducts are not dilated, the common bile duct is 6 mm, the gallbladder is of normal size, the wall is 2 mm, stones are
not visualized. The pancreas of increased echogenicity, heterogeneous, duct - 2 mm, the head is enlarged in volume
(33 mm), heterogeneous, increased echogenicity.
The task:
5) Principles of treatment
antisecretory therapy.
PPI: Esomeprazole 20 mg twice a day, 40 minutes before meals
Pantoprazole 40 mg 2 times a day, 40 minutes before meals
Rabeprazole 20 mg x 2 times a day, 40 minutes before meals
Lansoprazole 30 mg x 2 times a day, 40 minutes before meals
Omeprazole 20 mg x 2 times a day, 40 minutes before meals
H2 blockers: Famotidine 40-60 mg 2 times a day, 40 minutes before meals
Ranitidine 150 mg 2 times a day, 40 minutes before meals
OAM:
Amount of urine - 100 ml
Color - light yellow
Transparency - transparent
Relative density - 1020
pH - 6.0
LEU-neg
NIT - neg
PRO-neg
GLU-norm
KET-neg
UBG–neg
BIL–norm
ERI - neg
Microcytic hyporegenerative, hypochromicIron deficiency anemia, severe(hemoglobin-49g / l), due to the loss of a
large amount of blood during uterine bleeding after childbirth
Based
complaints: severe weakness, dizziness, palpitations. Sick for the last 2 months
history: childbirth 5 months ago, for the last 2-3 months, weakness has appeared and is growing, it has become
difficult to work - “no strength”, dizzy, it is difficult to breathe during exercise and the heart beats often. I noticed that
sometimes I want to eat chalk. He notes that his nails have become brittle, his hair falls out.
objective research:pale skin, dull and brittle hair, brittleness and change in the configuration of the nails (spoon-
shaped impression of the nail), "geographic tongue", seizures in the corners of the mouth At auscultation of the heart
at the apex of the heart, systolic murmur, heart rate 98
laboratory research:in the general blood test: hypochromic anemia, poikilocytosis, anisocytosis; in a bc blood test: a
decrease in serum iron, an increase in TI
4) Assign a treatment
1) non-drug treatment
- A diet rich in iron is indicated. The patient is recommended foods containing iron: beef, fish, liver, eggs, greens,
vegetables, oatmeal, buckwheat, wheat, beans, chocolate, fruits, raisins, prunes, etc.
2) drug treatment
It is carried out only with Fe preparations, mainly oral, less often parenteral, for a long time, under the control of a
detailed blood test. Oral preparations of ferrous sulfate are usually taken. With intolerance to ferrous sulfate, iron
gluconate and fumarate preparations are taken. Dosage: for adults 200 mg, for children 1.5-2 mg/kg. Additionally,
ascorbic acid is prescribed (200 mg for every 30 mg of iron), and succinic acid (185 mg per 37 mg of iron) for better
absorption of iron.
Treatment result: Restoration of iron stores in the depot occurs no earlier than 3 months from the start of treatment.
The criterion for the effectiveness of treatment with iron preparations is an increase in reticulocytes (reticulocyte crisis)
by 3–5 times on the 7–10th day from the start of therapy (with a single control, it is not always recorded).
Prevention of IDAshould be carried out in the presence of hidden signs of Fe deficiency or risk factors for its
development. The study of Hb, serum Fe should be performed at least once a year, and in the presence of clinical
manifestations as needed in patients: donors; pregnant women, women with prolonged (more than 5 days) and heavy
bleeding, premature babies and children born from multiple pregnancies; patients with constant and difficult to
eliminate blood loss; long-term NSAIDs
Case 10 V12-def
Situational task:You are a local doctor in a polyclinic. A 67-year-old man was admitted with complaints
ofshortness of breath when walkingdizziness, impaired concentration, loss of appetite, weight loss, epigastric discomfort,
pain and burning sensation in the tongue, periodically loosening of the stool; pain and numbness in the lower extremities,
muscle weakness ("wadded legs").
History: Sick for about 2 months, when fatigue, severe dizziness, impaired concentration appeared. Gradually joined
by shortness of breath when walking, weakness, tingling in the limbs, legs "wadded" - it is difficult to walk; loss of
appetite, weight loss. Recently, these complaints have intensified. I did not go to the doctor for the entire time of the
illness. 2 years ago, during the examination, gastritis and pancreatitis were exposed, but he did not receive treatment.
In the last week he has noticed a sharp deterioration, in connection with which he consulted a doctor.
Objectively: The skin is pale with an icteric tint, the sclera are subicteric. The muscles of the extremities are
atrophied, the muscle tone is reduced. Neurological status: The gait is unsteady, uncertain, movements are
uncoordinated. BP 95/60 mm Hg Heart rate 100 bpm. The tongue is moist, bright red in color, smooth - "varnished"
(due to the pronounced smoothness of the papillae), there are single aphthae on the buccal mucosa. The liver
protrudes 2.0 cm from under the edge of the costal arch, the surface is smooth, the consistency is pasty, the spleen is
not enlarged.
UAC: TANK:
HGB - 74 g/L reduced 120-140 130-160 creatinine 83 µmol/l norm 44-106
WBC(leukocytes)– 3.0 x 109 /L reduced 4-9 urea 4.2 mmol / l norm 2.4-6.4
RBC(erythrocytes)– 2, 8 x 1012 /L reduced 3.7- ALT 18 U/l norm up to 45
4.7 4-5.1 AST 22 U/l norm up to 47
LYM - 30% norm 18-40 Total bilirubin: 44.0 µmol/l increased 8-20
MID(monocytes, eosinophils, basophils and Indirect bilirubin: 40.0 µmol/l increased to 13
immature cells)– 6% norm 3-7 The content of vit. Serum B12 -
GRA - 60% norm 50-75 70 pg/ml reduced (160-950 pg/ml).
MCHC(mid.conc hemoglobin in erythrocytes)– serum iron: 15.6 µmol/l normal (9-27)
265 g\L reduced (300-380) EFGDS + biopsy:atrophic changes in the mucous
PLT (platelets) - 185 x 109 / L norm 180-320 membrane of the digestive tract. Atrophy of parietal
CPU-1.3 increased 0.85-1.05 and chief cells. Atypical cells were not found.
Microscopy: hyperchromia of erythrocytes,
anisocytosis (macrocytes, megalocytes),
poikilocytosis, Jolly bodies, Cabot rings,
hypersegmentation of neutrophil nuclei, ESR -
35 mm/h increased 2-15 1-10.
OAM:
Amount of urine - 100 ml
Color - light yellow
Transparency - transparent
Relative density - 1020
pH - 6.0
LEU-neg
NIT-neg
PRO-neg
GLU-norm
KET-neg
UBG–neg
BIL–norm
ERI-neg
no changes
1) Preliminary diagnosis:Hyperchromic anemia of the 2nd degree of severity. B12 deficiency anemia.
Rationale:the patient shows all the symptoms of B12-deficiency anemia, which are indicated by the patient's
complaints, such as shortness of breath when walking (hypoxemia), dizziness, impaired concentration (due to
impaired myelination of neurons due to impaired formation of methionine components), decreased appetite, weight
loss ( the patient associates food intake with pain, so he tries to eat less, and this can also be caused by a lack of
important elements that are poorly absorbed due to atrophic gastritis), pain and burning in the tongue, periodically
loosening of the stool; paresthesia, epigastric pain
At the same time, it is known from the anamnesis of the disease that he has chronic diseases, such as gastritis and
pancreatitis. In turn, it was gastritis that led to impaired absorption of vitamin B12 and the development of B12-
deficiency anemia.
The development of B12-deficiency anemia is also indicated by physical examination data, such as pallor of the skin
with an icteric tint, subicteric sclera, muscles are atrophied, a shaky gait, uncoordinated movements, a “lacquered”
tongue, single aphthae, hepatomegaly are determined.
2) Interpretation of laboratory and instrumental data
UAC:
● Decreased hemoglobin level (norm for men 130-160 g/l)
● Decrease in the level of erythrocytes (the norm for men is 3.7-4.7 * 10 ^ 12 / l)
● Decrease in the level of leukocytes (norm 4-9 * 10 ^ 9 / l)
● Platelets are normal (180-320*10^9/l)
● Lymphocytes are normal (18-40%)
● Monocytes are normal (2-9%)
● Granulocytes are normal (50-70%)
● The average concentration of hemoglobin in the blood is normal (260-340 g / l)
● CPU boost (normal 0.85-1.15)
● Microscopy revealed hyperchromia of erythrocytes (normochromia), anisocytosis, poikilocytosis, Jolly bodies,
Kebot rings, hyperpigmentation of neutrophil nuclei (all these blood microscopy data are characteristic of B12-
deficiency anemia and should not be normal)
● ESR acceleration (norm 2-15 mm/h)
microcytic, hyperchromic, hyporegenerative anemia
TANK:
● The level of creatinine is normal (62-106 µmol/l)
● The level of urea is normal (2.8-7.2 µmol/l)
● ALT/AST normal (up to 45 U/l/up to 41 U/l)
● Increase in the level of total bilirubin (norm 8.5-20.5 µmol / l)
● Increasing the level of indirect bilirubin (normal 1-8 µmol / l)
● Decreases in serum vitamin B12 levels (normal 160-950 pg/ml)
● Serum iron level is normal (12-29 µmol/l)
OAM:
● Bilirubin in urine (normally absent)
EFGDS + biopsy:
● EFGDS revealed atrophic changes in the mucous membrane of the digestive tract and atrophy of the parietal
and chief cells, which also indicates the presence of B12-deficiency anemia and the development of its complication -
atrophic gastritis.
4) Treatment:
Non-drug:
● Quitting smoking and drinking alcohol
● Balanced diet, with a high content of vitamin B12 in foods (beef, pork and chicken liver, mackerel, rabbit meat,
beef, sea bass, pork, cod, carp, chicken egg, sour cream)
Medical:
● 3. Pathogenetic therapy Cyanocobalamin 200-500 mcg, 1r/day s/c for 4-6 weeks. After normalization of the
blood composition (after about 1.5-2 months), 1 r / week is administered for 2-3 months, then 2 r / month for
six months. 6 injections per course)
● Etiotropic therapy Treatment of atrophic gastritis with replacement therapy (only during an exacerbation)
betaine + pepsin.
● Phytotherapy of atrophic gastritis: infusion of plantain leaves, chamomile, mint, St. 3-4 weeks
● Vitamins B1, B2, folic acid
● If H.pylori is detected, eradication therapy is carried out
Male R., 45 years old, complains of swelling and sharp pain in the first toe of the right foot, restriction of movement,
headaches.
From history:He fell ill acutely 2 days ago: after visiting the sauna and a plentiful feast at night, there was a very strong
pain in the first toe of the right foot. In the morning the patient noticed swelling of the first toe of the right foot and
purple coloration of the skin above it. Body temperature increased to 37.8 °C, and therefore applied to the clinic at the
place of residence.
From the history of life:over the past 3 years, rises in blood pressure up to 160/100 mm Hg have been observed
occasionally, and he has not received constant antihypertensive therapy.
Objectively:In the lungs, vesicular breathing, no wheezing. Respiratory rate - 18 per minute. Heart sounds are slightly
muffled, the rhythm is correct. Heart rate - 84 per minute. BP - 150/105 mm Hg. The abdomen is soft and painless.
The liver and spleen are not enlarged. The area of the kidneys is not visually changed. The symptom of tapping is
negative on both sides. There are no peripheral edema.
Articular syndrome in the form of monoarthritis; unilateral lesion of the first metatarsophalangeal joint, which reached
its maximum on the 1st day; a trigger factor for the development of acute arthritis is a stay in the sauna followed by a
plentiful feast.
Examination of the joints (examination, determination of the color of the skin, local temperature over the joint, pain,
range of motion in the joint): The affected joint is the first metatarsophalangeal joint of the right foot, edematous,
hyperemia and hyperthermia are determined above it, the range of motion in the joint is sharply limited due to pain
and edema. Other joints are not changed, their palpation is painless, movements are in full.
3) Preliminary diagnosis
Main diagnosis: Gout: acute gouty arthritis of the first metatarsophalangeal joint on the right. Concomitant disease:
arterial hypertension II degree.
-X-ray of feet- without pathological changes (since the patient has the first attack of gouty arthritis; subcortical cysts
without erosion are possible),
For the period of acute arthritis, rest and cold are needed on the area of the affected joint.
Teaching the patient the right way of life (reducing body weight with obesity, diet, reducing alcohol intake, especially
beer).
Elimination of risk factors for exacerbation of arthritis, revision of the drugs used in the treatment of concomitant
diseases that cause hyperuricemia in this category of patients (primarily diuretics, acetylsalicylic acid).
Mode: II DIET (table No. 6). Restriction of purines (shellfish, anchovies, red meat, offal), low-calorie diet, abundant
alkaline drinking up to 2-3 l / day, exclusion of ethanol-containing drinks, especially beer, restriction of carbohydrates
and the inclusion of polyunsaturated fatty acids in the diet are shown.
- Medical treatment:
List of additional medicines: Benzbromarone; Losartan (angiotensin 2 receptor antagonist for hypertension);
Fenofibrate; Omeprazole.
Big Criteria:
joint syndrome -knee joints - arthritis (monoarthritis)
Small Criteria :
fever, arthralgia
4) Diagnosis plan
complete blood count (CBC): increased ESR, possibly leukocytosis with a shift of the leukoformula to the left;
blood chemistry(AlT, AST, total protein and fractions, glucose, creatinine, urea, cholesterol);
coagulogram;
immunological blood test:C reactive protein (CRP) (positive), Rheumatoid factor (RF) negative, Antistreptolysin-O
(ASL-O) elevated or, more importantly, titers increasing in dynamics;
bacteriological examination: throat swab for the determination of B-hemolytic streptococcus group A (BSHA) -
detection of GABHS in a throat swab, can be both with active infection and with carriage.
ECG:clarification of the nature of cardiac arrhythmias and conduction disorders (with concomitant myocarditis);
echocardiography: necessary for the diagnosis of valvular pathology of the heart and the detection of pericarditis. In
the absence of valvulitis, the rheumatic nature of myocarditis or pericarditis should be interpreted with great caution.
5) Treatment tactics
Non-drug treatment:
Non-drug treatment:
Bed rest for 2-3 weeks (for the period of disease activity);
− Medical treatment:
Medical
Symptomatic– antiplatelet agents, anticoagulants – warfarin, ACE inhibition (captopril, enalapril), calcium antagonist –
diltiazem, verapamil, beta-blockers – metoprolol, bisoprolol, ARBs, cardiac glycosides – digoxin, diuretics
Rheumatoid arthritis
- pain (on palpation, on movement), Decrease in the force of compression of the hand.
- Symmetrical swelling
- morning stiffness
3) Preliminary diagnosis
(early 6 months-1 year, deployed more than 1 year, late 2 years or more)
· I class - completely preserved opportunities for self-service, non-professional and professional activities.
· Class II - retained the possibility of self-service, non-professional activities, limited opportunities for professional
activities.
· Class III - self-service opportunities are preserved, opportunities for non-professional and professional activities are
limited.
- Immunological characteristics (CRP -on, RF -on, antibodies to the cyclic citrullinated peptide ACCP)
- RadiographyI of the hands and feet (periarticular osteoporosis, blurring of the contours of the joints., erosion on the
joint surfaces, narrowing of the joint cracks, ankylosis)
I - periarticular osteoporosis;
II - periarticular osteoporosis + narrowing of the joint space, there may be single erosions;
III - signs of the previous stage + multiple erosions + subluxations in the joints;
Bone densitometry
- ECG
- echocardiography
5) Treatment tactics
-Non-drug treatment: Avoid factors that can potentially provoke an exacerbation of the disease (intercurrent infections,
stress, etc.);
Quitting smoking and drinking alcohol; · Smoking may play a role in the development and progression of RA. An
association was found between the number of cigarettes smoked and RF positivity, erosive changes in the joints and
the appearance of rheumatoid nodules, as well as lung damage (in men);
Maintaining an ideal body weight; A balanced diet that includes foods high in polyunsaturated fatty acids (fish oil, olive
oil, etc.), fruits, vegetables, potentially suppresses inflammation, reduces the risk of cardiovascular complications;
Patient education (changing the stereotype of motor activity, etc.); Physiotherapy exercises (1-2 times a week);
Physiotherapy: thermal or cold procedures, ultrasound, acupuncture, laser therapy; Orthopedic benefits (prevention
and correction of typical joint deformities and instability of the cervical spine, orthoses, insoles, orthopedic shoes);
Sanatorium-and-spa treatment is indicated only for patients in remission; During the course of the disease, active
prevention and treatment of concomitant diseases are necessary.
- Medical treatment
PROBLEM RA
Woman 34 years old, accountant
Complaints: pain and swelling in the carpal and elbow, metacarpophalangeal and proximal interdigital joints of the
hand, morning stiffness, which lasts up to 12 hours, in the evening - low-grade fever.
Anamnesis: ill for the last 3 years. She took NSAIDs (ketonal), currently taking ketonal as an injection, the effect is
negligible.
Objectively:
Case 14
OSTEOARTHROSIS
50 year old woman....
Woman, 58 years old, pensioner
Complaints: pain that occurs when walking in the knee joints and disappears at rest. Morning stiffness lasts 30
minutes, limitation of movements in the knee joints, especially in the right knee (extension and flexion, squatting is
limited)
From the anamnesis: pain in the knee joints has been disturbing for the last 5 years. Physiotherapy, with severe pain,
he independently took non-steroidal anti-inflammatory drugs (diclofenac, ketonal), the effect was temporary. Over the
past month, the disease worsened, swelling appeared in the right knee joint.
Objective:
crepitus
An increase in the volume of the joint often occurs due to proliferative changes (osteophytes), but may also be the
result of edema of the periarticular tissues.
The formation of nodules in the distal (Heberden's nodes) and proximal (Bouchard's nodes) interphalangeal joints of
the hands.
Severe swelling and local temperature increase over the joints is rare, but may occur with the development of
secondary synovitis.
Varus deformity of the knee joints, "square" hand, Heberden's and Bouchard's nodes, respectively, in the distal and
proximal interphalangeal joints of the hands.
4) Survey plan
Instrumental research[1-6,14]:
X-ray of the affected joints; knee joints - uneven narrowing of the joint space, osteophytes, signs of osteosclerosis
Ultrasound of the joints in the presence of synovitis;
MRI of knee jointsfor differential diagnosis.
5) Treatment tactics
Non-drug treatment[1-4,9]:
Non-drug treatment
- physiotherapy exercises (the main task is to reduce the load on the joint and strengthen the muscles): correction of
posture and length of the lower limbs, exercises with isometric load, exercises for individual muscle groups;
X-ray stage II non-drug treatment, NSAIDs, intravenous administration of artificial synovial fluid preparations in
courses;
X-ray stage III non-drug treatment, NSAIDs, antidepressants and intravenous administration of artificial synovial fluid
preparations in courses;
ANALGESICS-paracetamol,
NSAIDs- diclofenac,
9. Piroxicam 10 mg tab.
13. *Nadroparin calcium - injection in pre-filled syringes 2850 IU anti-Xa / 0.3 ml; 3800 IU anti-Xa/0.4 ml; 5700 IU anti-
Xa/0.6 ml; 7600 IU anti-Xa/0.8 ml, 9500 IU anti-Xa/1.0 ml
Case 15
HRBS
1) Symptoms of CRPS
Mitral insufficiency: long-term patients do not complain, the defect can be detected during an accidental medical
examination. With the progression of the disease appear: shortness of breath during exercise, and then at rest, cough,
asthma attacks at night; acrocyanosis; cough with a small amount of sputum; pain in the right hypochondrium due to
an increase in the size of the liver; swelling of the legs and feet. Auscultatory-systolic murmur, reflecting mitral
regurgitation, has the following characteristics: long, intense, blowing; has a different duration and intensity, especially
in the early stages of the disease; does not change significantly when changing the position of the body and the phase
of breathing; associated with tone I and occupies most of the systole, and is optimally auscultated at the apex of the
heart, carried out in the left axillary region.
Mitral stenosis(narrowing of the left atrioventricular opening): cyanotic flush of the cheeks; heartbeat; swelling; pain in
the chest; general weakness, increased fatigue; asthma attacks at night; cough with sputum, sometimes streaked with
blood. Auscultatory-loud I tone of mitral valve opening, "quail rhythm", diastolic murmur in the apex of the heart.
Aortic valve insufficiency: pulsation on the carotid artery, in the region of the heart, a heartbeat noticeable to the eye;
pallor, dizziness, fainting; pain in the region of the heart that occurs during physical exertion; dyspnea; general
weakness, fatigue. Auscultatory sign: protodiastolic murmur at Botkin's point. Blood pressure: high - systolic, low -
diastolic.
Aortic stenosischaracterized by pain behind the sternum, which occurs during physical exertion; headache; dizziness;
dyspnea; increased fatigue; pallor of the skin; symptom of systolic "cat's purr". Arterial pressure is reduced to 100/60
mm Hg. and below.
2) Survey plan
• EchoCG - signs of damage to the heart valves (more often mitral insufficiency, less often aortic insufficiency, mitral
stenosis and concomitant defect).
4) Treatment tactics
Non-drug treatment:
Medical treatment
benzylpenicillin sodium salt; cefuroxime; azithromycin; benzathine benzylpenicillin; bicillin-5; diclofenac; aceclofenac;
etoricoxib; prednisolone; methylprednisolone
triamterene.
action (amlodipine).
the above drugs are similar to those in the treatment of congestive heart
NSAIDs and ACE inhibitors can lead to a weakening of the vasodilating effect of the latter.
In particular, with the development of cardiac decompensation as a consequence of acute valvulitis (which usually
occurs only in children), the use of cardiotonic drugs is inappropriate, since in these cases a clear therapeutic effect
can be achieved using high doses of prednisolone (40-60 mg per day) .
In patients with sluggish carditis against the background of RPS (rheumatic heart disease), when choosing drugs used
in the treatment of congestive heart failure, their possible interaction with anti-inflammatory drugs should be taken into
account.
osteoarthritis
From the anamnesis: pains in the knee joints have been disturbing for 10 years. She independently took non-steroidal
anti-inflammatory drugs (diclofenac) and treated her knee joints with salt, later painless nodes appeared in the distal
and proximal joints of the fingers. During the last 3 months, the pain in the joints, the crunching increased, and the
movements were also somewhat limited.
1. The patient complains of pain in the knee joints that occurs when walking and disappears at rest. There is also
morning stiffness lasting 10-15 minutes, with a crunch in the knee joints upon movement and limitation of movements
in the knee joints (especially in the prone and sitting position). Going down stairs is also difficult. These symptoms
have been present for 10 years, and the patient has self-medicated with non-steroidal anti-inflammatory drugs
(diclofenac) and treated her knee joints with salt. Painless nodes appeared in the distal and proximal joints of the
fingers, and over the last 3 months, the pain, crunching, and limited mobility have worsened.
2. The objective examination may reveal signs of joint inflammation, such as swelling, warmth, and tenderness in the
knee joints. There may also be crepitus (a crunching sensation) upon movement of the knee joint and limited range of
motion, particularly in flexion or extension. A physical exam of the fingers may also be warranted to evaluate for any
nodules or joint deformities.
3. The patient's symptoms and examination findings suggest a diagnosis of osteoarthritis (OA) of the knee joints. OA
is a degenerative joint disease characterized by progressive loss of cartilage in the joint, leading to pain, stiffness, and
limited range of motion. The development of nodes in the fingers is also a common feature of OA.
4. Additional tests that may be helpful in confirming the diagnosis and assessing disease severity include:
- X-rays of the knee joints to evaluate for joint space narrowing, bone spurs, and other signs of OA
- Blood tests to rule out other causes of joint pain, such as rheumatoid arthritis or gout.
5. Treatment for OA may include a combination of non-pharmacologic and pharmacologic interventions. Non-
pharmacologic treatments may include weight loss (if applicable), physical therapy, and assistive devices (e.g. knee
braces or shoe inserts). Pharmacologic treatments may include nonsteroidal anti-inflammatory drugs (NSAIDs),
acetaminophen, or intra-articular corticosteroid injections. In severe cases, joint replacement surgery may be
recommended. Treatment should be tailored to the individual patient's needs and preferences, with the goal of
improving pain and function and preserving joint mobility.
№8 – AS
1. The patient complains of pain in the cervical, thoracic, and lumbar vertebrae, morning stiffness that lasts until noon,
limitation of spinal movement, change in posture, and fatigue. These symptoms have been present for 25 years, and
the patient initially experienced pain in the lower back that occurred at rest and in the second half of the night, with
relief upon movement. The patient self-medicated with diclofenac, which had a positive effect. Over time, the pain and
stiffness spread to all parts of the spine, and there was a restriction of spinal movement and a change in posture. The
patient also had bilateral recurrent uveitis, for which they received treatment from an ophthalmologist.
2. The objective examination shows a flattened lumbar lordosis, tense rectus dorsi muscles, and pain on palpation in
the area of the ileosacral ligament. There is limited head rotation and forward tilt, limited inclination of the body to the
lateral edge, Thomayer's sign is 40 cm, Ott's sign is 2 cm, and Schober's sign is 1 cm.
3. The patient's symptoms and examination findings suggest a diagnosis of Ankylosing Spondylitis (AS), a type of
inflammatory arthritis that primarily affects the spine. AS is characterized by morning stiffness and pain that improves
with movement, spinal fusion leading to a loss of spinal mobility, and changes in posture. Recurrent uveitis is a
common extra-articular manifestation of AS.
4. Additional tests that may be helpful in confirming the diagnosis and assessing disease activity include:
- Blood tests to measure levels of inflammation (e.g. C-reactive protein, erythrocyte sedimentation rate)
5. Treatment for AS typically involves a combination of medication, exercise, and lifestyle modifications. Medications
may include nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation, disease-modifying
antirheumatic drugs (DMARDs) to slow disease progression, and biologic agents (e.g. TNF inhibitors) to target
specific inflammatory pathways. Exercise programs, such as physical therapy or yoga, can help improve spinal
mobility and posture. Lifestyle modifications may include avoiding smoking and maintaining a healthy weight.
Treatment should be tailored to the individual patient's needs and may require a multidisciplinary approach involving
rheumatologists, ophthalmologists, and other healthcare providers.
Clinical zhagday №9
SLE
The receptionist is a 19 year old girl.
Complaints: fatigue, weakness, pain in the knee, shoulder joints, rashes on the face, rash, sores in the hard palate of
the oral cavity, hair loss, fever up to 38.0 0C, weight loss of 2.5 kg of body weight per 2.5 weeks
From the anamnesis: according to the patient, they rested on Issyk-Kul (rested 20 days ago), rashes appeared on the
face, body temperature rose to 38 C, paracetamol, local Advantan ointment (containing methylprednisolone) were
used, there was a slight effect, then there were pains in knee and shoulder joints, ulcerative lesion of the hard palate
in the oral cavity, hair loss, weakness, fatigue, was at the therapist, during the examination: KLA: leukocytes - 3.0 x
109 / l, platelets - 170 x10 9 / l, erythr - 3.1 x10 12/l, HB-98 g/l, ESR 30 mm/h.
Objective:
Vesicular breathing in the lungs, no wheezing. RR 16 times min. The heart sounds are muffled, the rhythm is correct,
the pulse is 84 beats/min. BP 110 / 70 mmHg the tongue is moist and clean. The abdomen is soft and painless. Liver
in the right costal arch. The spleen is not enlarged. The symptom of effleurage is negative on both sides. Urination is
free, without pain.
Objectives:
1. The patient complains of fatigue, weakness, pain in the knee and shoulder joints, rashes on the face and body,
sores in the hard palate of the oral cavity, hair loss, fever, and weight loss. According to the anamnesis, the symptoms
started after a trip to Issyk-Kul, where rashes appeared on the face and a high fever followed. Treatment with
paracetamol and topical methylprednisolone had a slight effect. Subsequently, joint pain, oral ulcers, hair loss,
weakness, and fatigue developed.
2. On objective examination, the patient has vesicular breathing in the lungs without wheezing, a muffled heart sound
with a correct rhythm and a pulse of 84 beats/min, and a blood pressure of 110/70 mmHg. The tongue is moist and
clean, and the abdomen is soft and painless. The liver is palpable in the right costal arch, and the spleen is not
enlarged. The symptom of effleurage is negative on both sides, and urination is free without pain.
3. The patient's symptoms and laboratory findings suggest a systemic autoimmune disease, such as systemic lupus
erythematosus (SLE) or mixed connective tissue disease (MCTD). The presence of rashes, joint pain, oral ulcers, and
hair loss are all common symptoms of these diseases. The low leukocyte count and anemia seen on laboratory tests
may also be indicative of autoimmune disease.
4. Further laboratory testing may include antinuclear antibody (ANA) testing, anti-dsDNA, and anti-Sm antibody testing
to help confirm a diagnosis of SLE or MCTD. Additional imaging studies, such as X-rays or MRI, may be performed to
evaluate joint involvement.
5. Treatment will depend on the specific diagnosis, but may include nonsteroidal anti-inflammatory drugs (NSAIDs)
and corticosteroids to manage symptoms such as joint pain and inflammation. Immunomodulatory drugs, such as
hydroxychloroquine or methotrexate, may also be used to manage disease activity. Topical and systemic treatments
may be used for skin and oral involvement, and regular monitoring by a rheumatologist is important to ensure effective
disease management.
Clinical №10
scleroderma
Objective:
1. The patient has a history of frostbite and numbness in the hands, which can indicate poor blood circulation in the
fingers. The appearance of vascular patterns on the face and back, pain and swelling of the small joints of the hands,
hair loss, weakness and fatigue can be signs of an autoimmune disease. An increase in CRP and ESR levels in the
blood test further suggest an inflammatory process.
2. The objective examination reveals no additional information to aid in the interpretation of the patient's symptoms
and history.
3. The diagnosis is systemic sclerosis (scleroderma), an autoimmune connective tissue disease characterized by the
hardening and tightening of the skin and connective tissues, as well as the malfunctioning of blood vessels and
internal organs.
4. Additional tests such as ANA (antinuclear antibodies) and anti-Scl-70 (anti-topoisomerase) antibody tests can
confirm the diagnosis of scleroderma. Imaging studies such as chest x-ray, echocardiogram, or pulmonary function
tests may be ordered to assess the involvement of internal organs.
5. Treatment for scleroderma aims to manage symptoms, slow down the progression of the disease, and prevent
complications. Medications such as immunosuppressants, vasodilators, and pain relievers may be prescribed.
Physical therapy and occupational therapy can help improve mobility and function. Additionally, lifestyle modifications
such as avoiding cold temperatures and quitting smoking can also help manage symptoms.